Total Payments
$13,280
2024 Payments
$751.95
Companies
19
Transactions
189
Medicare Patients
1,054
Medicare Billing
$141,632
Payment Breakdown by Category
Other$9,500 (71.5%)
Food & Beverage$3,602 (27.1%)
Education$178.22 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,500 | 8 | 71.5% |
| Food and Beverage | $3,602 | 176 | 27.1% |
| Education | $178.22 | 5 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $9,685 | 29 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $650.69 | 28 | $0 (2024) |
| ABBVIE INC. | $643.80 | 29 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $529.70 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $388.97 | 22 | $0 (2023) |
| Alkermes, Inc. | $259.71 | 13 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $236.50 | 8 | $0 (2024) |
| Axsome Therapeutics, Inc. | $149.06 | 3 | $0 (2024) |
| ITI, Inc. | $127.47 | 7 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $126.33 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $751.95 | 27 | Vanda Pharmaceuticals Inc. ($221.10) |
| 2023 | $709.96 | 32 | AbbVie Inc. ($285.27) |
| 2022 | $646.78 | 34 | ABBVIE INC. ($265.81) |
| 2021 | $1,572 | 12 | Allergan, Inc. ($1,300) |
| 2020 | $3,104 | 12 | Allergan, Inc. ($3,039) |
| 2019 | $5,719 | 37 | Allergan Inc. ($5,306) |
| 2018 | $530.99 | 21 | Teva Pharmaceuticals USA, Inc. ($113.95) |
| 2017 | $245.16 | 14 | Otsuka America Pharmaceutical, Inc. ($133.51) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $36.01 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $30.19 | General |
| 11/14/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $35.38 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $116.32 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: CNS | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: PSYCHIATRY | ||||||
| 08/02/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: SCHIZOPHRENIA | ||||||
| 07/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Neurology | ||||||
| 06/27/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/06/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.08 | General |
| Category: PSYCHIATRY | ||||||
| 04/18/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: SCHIZOPHRENIA | ||||||
| 04/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: PSYCHIATRY | ||||||
| 04/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Central Nervous System | ||||||
| 03/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: PSYCHIATRY | ||||||
| 03/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $37.68 | General |
| Category: SCHIZOPHRENIA | ||||||
| 02/01/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: PSYCHIATRY | ||||||
| 01/31/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.57 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 183 | 495 | $105,731 | $37,174 |
| 2022 | 9 | 272 | 554 | $92,964 | $34,780 |
| 2021 | 7 | 239 | 553 | $69,097 | $26,838 |
| 2020 | 8 | 360 | 800 | $120,829 | $42,840 |
Total Patients
1,054
Total Services
2,402
Medicare Billing
$141,632
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 30 | 128 | $33,920 | $13,361 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 155 | $39,412 | $12,168 | 30.9% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 31 | 53 | $10,620 | $6,210 | 58.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 17 | 17 | $10,457 | $2,437 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 48 | $6,128 | $2,282 | 37.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 26 | 36 | $3,744 | $443.04 | 11.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 58 | $1,450 | $273.26 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 103 | $26,136 | $8,239 | 31.5% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2022 | 38 | 61 | $10,057 | $7,305 | 72.6% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 20 | 59 | $15,635 | $6,670 | 42.7% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 25 | 54 | $9,450 | $3,820 | 40.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 22 | 22 | $13,131 | $3,269 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 51 | $6,575 | $2,679 | 40.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 54 | 80 | $7,872 | $1,143 | 14.5% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 13 | 16 | $1,408 | $891.66 | 63.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 33 | 108 | $2,700 | $763.45 | 28.3% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 25 | 116 | $20,300 | $8,351 | 41.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 77 | $19,811 | $6,165 | 31.1% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2021 | 25 | 37 | $6,586 | $4,641 | 70.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 87 | $11,387 | $4,340 | 38.1% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 16 | 33 | $2,904 | $1,575 | 54.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 47 | 165 | $4,125 | $1,246 | 30.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 35 | 38 | $3,984 | $519.01 | 13.0% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 46 | 198 | $34,650 | $13,820 | 39.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 92 | 192 | $24,727 | $9,603 | 38.8% |
About Dr. Kellie Bishop, M.D
Dr. Kellie Bishop, M.D is a Psychiatry healthcare provider based in Hilton Head Island, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1245413723.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kellie Bishop, M.D has received a total of $13,280 in payments from pharmaceutical and medical device companies, with $751.95 received in 2024. These payments were reported across 189 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,500).
As a Medicare-enrolled provider, Bishop has provided services to 1,054 Medicare beneficiaries, totaling 2,402 services with total Medicare billing of $141,632. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Hilton Head Island, SC
- Active Since 12/07/2007
- Last Updated 12/07/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1245413723
Products in Payments
- VRAYLAR (Drug) $10,262
- ABILIFY MAINTENA (Drug) $492.37
- INVEGA SUSTENNA (Drug) $348.39
- AUSTEDO (Drug) $256.06
- CAPLYTA (Drug) $170.26
- FANAPT (Drug) $159.89
- ARISTADA (Drug) $155.30
- Auvelity (Drug) $149.06
- REXULTI (Drug) $133.53
- INGREZZA (Drug) $126.33
- ABILIFY ASIMTUFII (Drug) $109.21
- Catalys Laser System (Device) $107.41
- Austedo XR (Drug) $77.45
- ENVISTA (Device) $62.79
- HETLIOZ (Drug) $61.21
- Aristada 441 mg (Drug) $54.49
- UZEDY (Drug) $53.21
- LYBALVI (Drug) $49.92
- XIIDRA (Drug) $34.31
- SPRAVATO (Drug) $25.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.